Shine Investment Advisory Services’s Adaptive Biotechnologies ADPT Stock Holding History

Shine Investment Advisory Services’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$13K	Sell	269 -368	-58%	-$15.5K	﹤0.01%	506
2020 Q2	$31K	Hold	637	–	–	0.01%	390
2020 Q1	$18K	Buy	637 +338	+113%	+$9.43K	0.01%	433
2019 Q4	$9K	Buy	299 +110	+58%	+$3.16K	﹤0.01%	583
2019 Q3	$6K	Buy	+189	New	+$7.71K	﹤0.01%	633

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SIG

Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return

Shine Investment Advisory Services's ADPT Position: Q3 2020 in Review

Shine Investment Advisory Services reduced its Adaptive Biotechnologies (ADPT) stake by 58% in Q3 2020, selling an estimated $15.5K and leaving 269 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #506.

Shine Investment Advisory Services first reported a position in ADPT in Q3 2019 and has held it in 5 quarters since. The position peaked at $31K in Q2 2020. 206 funds tracked by Wall St. Rank hold ADPT as of Q3 2020.

Shine Investment Advisory Services held 269 shares of Adaptive Biotechnologies worth $13K as of Q3 2020.
Shine Investment Advisory Services sold 368 Adaptive Biotechnologies shares in Q3 2020, an estimated $15.5K.
Adaptive Biotechnologies made up ﹤0.01% of Shine Investment Advisory Services's portfolio in Q3 2020, its #506 holding.
Shine Investment Advisory Services first reported a position in Adaptive Biotechnologies in Q3 2019 and has held it in 5 quarters since.
Shine Investment Advisory Services's Adaptive Biotechnologies position peaked at $31K in Q2 2020.
206 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.